Using a DNA-binding ELISA-based assay, we analyzed p65 and p52 NF-κB activity in nuclear extracts from MYD88-mutated and MYD88-unmutated CLL samples. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.